Zhen et al. discovered that AT406, an IAP antagonist, induced degradation of IAPs (cIAP-1 and XIAP) and exhibited cytotoxic and pro-apoptotic effects on HepG2, SMMC-7721 cell lines, and primary HCC cells 35. This evidence concerns the gene BIRC2 and hepatocellular carcinoma.